Max Rady College of Medicine
ON2076 - 675 McDermot Avenue
Winnipeg, Manitoba R3E 0V9
CancerCare Manitoba Research Institute
Dr. Houston's training involved the use of next-generation sequencing technology to identify structural abnormalities, or mutations in the DNA of cancer cells, and understanding the consequences of these mutations to cancer cell growth using high-throughput functional screens. He has applied these novel technologies to a variety of malignancies including breast cancer, lung cancer, and sarcoma.
Dr. Donald Houston is an associate professor of internal medicine at the University of Manitoba. He is also Course director of the blood and immunology undergraduate medical school course, Health Sciences Centre site director for the hematology residency training program, and research director of the internal medicine residency training program.
Dr. Houston is a hematologist, researcher and educator based at CancerCare Manitoba, the Health Sciences Centre, and the University of Manitoba.
His clinical interests cover the gamut of general hematology, including anemias, hemoglobinopathies, bleeding disorders, thrombosis, myelodysplasias, and myeloproliferative disorders. His active research interests are in the areas of bleeding disorders and anemias.
Nationally, he is a board member of the Association of Hemophilia Clinic Directors of Canada and also the Director of the Manitoba Institute of Theoretical Hematology.
Dr. Houston’s medical and scientific training took him to the Universities of Saskatchewan Manitoba, McMaster, Oklahoma and the Mayo Clinic.